Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

RBC Capital Maintains Outperform on IDEX, Raises Price Target to $255

Author: Benzinga Newsdesk | February 08, 2024 11:16am
RBC Capital analyst Deane Dray maintains IDEX (NYSE:IEX) with a Outperform and raises the price target from $234 to $255.

Posted In: IEX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist